pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

6,918 products tracked · 6,918 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Marketed
ceftazidime
Ceftazidime (ceftazidime)
Septic Arthritis
ACS Dobfar SpA
0 catalysts
Marketed
ceftobiprole medocaril
Zevtera (ceftobiprole medocaril)
Community-Acquired Bacterial Pneumonia
Innoviva Specialty Therapeutics Inc
0 catalysts
Marketed
ceftriaxone sodium
Ceftriaxone Sodium (ceftriaxone sodium)
Lower Respiratory Tract Infections
Piramal Critical Care Inc
0 catalysts
← prev
page 164 of 231
next →
131
Pain89
Neurology1
Marketed
cefuroxime axetil
Cefuroxime Axetil (cefuroxime axetil)
Maxillary Sinusitis
Orchid Pharma Inc
0 catalysts
Marketed
cefuroxime sodium
Cefuroxime Sodium (cefuroxime sodium)
Urinary Tract Infections
ACS Dobfar SpA
0 catalysts
Phase 3
celiprolol
EDSIVO (celiprolol [INN])
Ehlers-Danlos Syndrome Vascular Type (Type IV)
$ZVRAZEVRA THERAPEUTICS, INC.
0 catalysts
Phase 2
cemacabtagene ansegedleucel
Primary Mediastinal B-Cell Lymphoma
$ALLOAllogene Therapeutics, Inc.
0 catalysts
pre_registration
cemdisiran
Myasthenia Gravis
Complement C5 mRNA
$REGNREGENERON PHARMACEUTICALS, INC.
0 catalysts
Phase 3
cemdisiran + pozelimab
Myasthenia Gravis
$REGNREGENERON PHARMACEUTICALS, INC.
0 catalysts
Phase 2
cemsidomide
Anaplastic Large Cell Lymphoma (ALCL)
$CCCCC4 Therapeutics, Inc.
0 catalysts
Phase 2
cenegermin
Oxervate (cenegermin-bkbj)
Non-Arteritic Anterior Ischemic Optic Neuropathy
Neurotrophic tyrosine kinase receptor
Dompe Farmaceutici SpA
0 catalysts
Phase 3
cenerimod
Systemic Lupus Erythematosus
Sphingosine 1-phosphate receptor 1
Idorsia Pharmaceutical Ltd
0 catalysts
Marketed
cenobamate
Xcopri (cenobamate)
Tonic-Clonic (Grand Mal) Seizure
Sodium channel alpha subunitGABA-A receptor; anion channel
SK Life Science Inc
0 catalysts
Phase 2
censavudine
Amyotrophic Lateral Sclerosis
Human immunodeficiency virus type 1 reverse transcriptaseReverse transcriptase
Transposon Therapeutics Inc
0 catalysts
pre_registration
centanafadine SR
centanafadine
Attention Deficit Hyperactivity Disorder (ADHD)
Monoamine transporter
Otsuka Pharmaceutical Co Ltd
0 catalysts
Marketed
centany
Centany (mupirocin)
Impetigo
Medimetriks Pharmaceuticals Inc
0 catalysts
Marketed
cephalexin
Cephalexin (cephalexin)
Chronic Bacterial Prostatitis
Belcher Pharmaceuticals LLC
0 catalysts
Phase 2
cerebrolysin
Unspecified Neurologic Disorders
EVER Neuro Pharma GmbH
0 catalysts
Preclinical
cerium oxide
Radiodermatitis
BioCurity Pharmaceuticals Inc
0 catalysts
Marketed
cerliponase alfa
Brineura (cerliponase alfa)
Batten Disease
$BMRNBIOMARIN PHARMACEUTICAL INC
0 catalysts
Phase 2
certepetide
Bile Duct Cancer (Cholangiocarcinoma)
$LSTALISATA THERAPEUTICS, INC.
0 catalysts
Phase 3
cetoquagene parvec
Xerostomia
$MGTXMeiraGTx Holdings plc
0 catalysts
Phase 2
cetrelimab
Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer)
Programmed cell death protein 1
$JNJJOHNSON & JOHNSON
0 catalysts
Marketed
cetrorelix acetate
Cetrotide (cetrorelix acetate)
Female Infertility
EMD Serono Inc
0 catalysts
Marketed
cetuximab
Erbitux (cetuximab)
Head And Neck Squamous Cell Carcinoma (HNSC)
Eli Lilly Interamerica Inc
0 catalysts
Phase 3
cetuximab sarotalocan
Recurrent Head And Neck Squamous Cell Carcinoma
Epidermal growth factor receptor
Rakuten Medical Inc
0 catalysts
Phase 2
cevaretigene ritoparvovec
Leber Congenital Amaurosis (LCA)
$MGTXMeiraGTx Holdings plc
0 catalysts
Phase 2
cevidoplenib
cevidoplenib [INN]
Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura)
Genosco Inc
0 catalysts
Phase 2
cevostamab
Refractory Multiple Myeloma
Genentech Inc
0 catalysts
Preclinical
chikungunya vaccine
Vimkunya
Chikungunya Fever
Hawaii Biotech Inc
0 catalysts